Regeneron Pharmaceuticals Inc. (REGN) Statistics & Valuation Metrics - Stocknear

Regeneron Pharmaceuticals...

NASDAQ: REGN · Real-Time Price · USD
573.38
6.16 (1.09%)
At close: Sep 05, 2025, 3:59 PM
571.99
-0.24%
After-hours: Sep 05, 2025, 07:50 PM EDT

Regeneron Pharmaceuticals Statistics

Share Statistics

Regeneron Pharmaceuticals has 104.17M shares outstanding. The number of shares has increased by -2.09% in one year.

104.17M
-2.09%
-1.27%
86.23%
102.13M
5,581
0.55%

Short Selling Information

The latest short interest is 2.35M, so 2.18% of the outstanding shares have been sold short.

2.35M
2.18%
2.29%
2.21

Valuation Ratios

The PE ratio is 17.42 and the forward PE ratio is 14.02. Regeneron Pharmaceuticals's PEG ratio is 1.68.

17.42
14.02
5.41
4.1
2.62
20.97
1.68
Financial Ratio History

Enterprise Valuation

Regeneron Pharmaceuticals has an Enterprise Value (EV) of 77.08B.

5.43
14.49
17.44
21.03

Financial Position

The company has a current ratio of 4.73, with a Debt / Equity ratio of 0.09.

4.73
3.95
0.09
0.51
0.74
75.61

Financial Efficiency

Return on Equity is 15.03% and Return on Invested Capital is 11.39%.

15.03%
11.69%
11.39%
$936.93K
$291.11K
15,158
0.38
0.79

Taxes

367.3M
7.68%

Stock Price Statistics

The stock price has increased by -49.33% in the last 52 weeks. The beta is 0.35, so Regeneron Pharmaceuticals's price volatility has been higher than the market average.

0.35
-49.33%
560.96
626.69
51.26
1,022,070

Income Statement

In the last 12 months, Regeneron Pharmaceuticals had revenue of 14.2B and earned 4.41B in profits. Earnings per share was 40.9.

14.2B
11.75B
4.17B
4.41B
5.32B
4.84B
40.9
Full Income Statement

Balance Sheet

The company has 2.49B in cash and 2.7B in debt, giving a net cash position of -216.2M.

2.49B
2.7B
-216.2M
31.67B
38.22B
13.19B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.42B and capital expenditures -755.9M, giving a free cash flow of 3.66B.

4.42B
-755.9M
3.66B
33.96
Full Cash Flow Statement

Margins

Gross margin is 82.74%, with operating and profit margins of 29.39% and 31.07%.

82.74%
29.39%
33.66%
31.07%
37.45%
29.39%
25.8%

Dividends & Yields

REGN does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
5.74%
4.77%
Dividend Details

Analyst Forecast

The average price target for REGN is $790.5, which is 37.9% higher than the current price. The consensus rating is "Buy".

$790.5
37.9%
Buy
21
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

$204.5
-64.33%
500.32
-12.74%

Scores

6.78
5